FDA Gives Breakthrough Device Status to nVNS for PTSD Doug Bremner Psychiatry January 15, 2022The Food and Drug Administration (FDA) on January 12, 2022, granted breakthrough status to the GammaCore non-invasive Vagal Nerve Stimulation...
